薦椎神經刺激(SNS) 市場規模、佔有率和成長分析（按產品、應用和地區）- 產業預測 2025-2032

2023 年全球薦椎神經刺激(SNS) 市場規模價值 12 億美元，預測期內（2025-2032 年）的複合年成長率為 14.0%，從 2024 年的 13.7 億美元成長至 2032 年的 39 億美元。預計將成長至1000億美元。

全球薦椎神經刺激（SNS）市場正在成長，這主要是由於尿道感染（UTI）、膀胱過動症（OAB）、急性尿失禁失禁和其他疾病的發生率上升。 SNS 技術涉及植入一種薦骨神經傳送電脈衝的裝置，能夠有效增強那些對傳統治療方法沒有反應的患者對膀胱和腸道的控制能力。美國約有 1300 萬成年人患有尿失禁，其中大多數是女性，因此 SNS 作為安全有效的解決方案的吸引力顯而易見。由於老年人中大便失禁的盛行率不斷上升，尤其是在英國，市場預計會擴大，因為這種使人衰弱的疾病對生活品質和社交互動有重大影響。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究

薦椎神經刺激(SNS) 市場規模（依產品）

• 市場概況
• 嵌入式 SNS 設備
• 外部 SNS 設備

薦椎神經刺激(SNS) 市場規模（依應用）

• 市場概況
• 尿失禁和大便失禁
• 慢性肛門裂傷
• 急性尿失禁
• 其他

薦椎神經刺激（SNS）市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Medtronic（USA）
• NeuroPace, Inc.（USA）
• Nevro Corp.（USA）
• Boston Scientific Corporation（USA）
• Synapse Biomedical Inc.（USA）
• Johnson & Johnson（USA）
• Biomedical Life Systems Inc.（USA）
• Kegel8（Savantini Limited）（UK）
• EnteroMedics Inc.（USA）
• LivaNova PLC（UK）
• Inspire Medical Systems Inc.（USA）
• Beijing PINS Medical Co., Ltd.（China）
• Saluda Medical Pty Ltd.（Australia）

結論和建議

Global Sacral Nerve Stimulation (SNS) Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.37 billion in 2024 to USD 3.9 billion by 2032, growing at a CAGR of 14.0% during the forecast period (2025-2032).

The global Sacral Nerve Stimulation (SNS) market is on an upward trajectory, primarily driven by the rising incidence of urge incontinence, including conditions like Urinary Tract Infections (UTI), Overactive Bladder (OAB), and fecal incontinence. SNS technology involves implanting a device that sends electrical impulses to the sacral nerves, effectively enhancing bladder and bowel control in patients who have not found relief through traditional therapies. With around 13 million adults in the U.S. affected by urinary incontinence, predominantly women, the appeal of SNS as a safe and effective solution is evident. The increasing prevalence of fecal incontinence, particularly among the elderly in the UK, underscores a growing market, as this debilitating condition significantly impacts quality of life and social interaction.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacral Nerve Stimulation (Sns) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sacral Nerve Stimulation (SNS) Market Segmental Analysis

Global Sacral Nerve Stimulation (SNS) Market is segmented by Product, Application and region. Based on Product, the market is segmented into Implantable SNS Devices and External SNS Devices. Based on Application, the market is segmented into Urinary and Fecal Incontinence, Chronic Anal Fissure, Urge Incontinence and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sacral Nerve Stimulation (SNS) Market

The global Sacral Nerve Stimulation (SNS) market is experiencing significant growth due to a surge in cases of urge incontinence, including conditions like Urinary Tract Infections (UTIs) and a rising incidence of Overactive Bladder (OAB) and fecal incontinence. SNS presents an effective treatment alternative for patients who have not found relief through conventional therapies or medications. The increasing prevalence of urinary and fecal disorders, especially among the elderly, propels the demand for SNS devices. This market driver is primarily motivated by the urgent need to enhance the quality of life for affected individuals, improve bladder function, and reduce the adverse effects of these issues on daily living.

Restraints in the Global Sacral Nerve Stimulation (SNS) Market

A notable restraint within the global Sacral Nerve Stimulation (SNS) market is the substantial financial burden associated with the devices and their associated procedures. The costs of procuring the SNS device, conducting the surgical implantation, and managing follow-up care and potential complications can deter both patients and healthcare providers from pursuing this treatment option. Furthermore, restrictive reimbursement policies and limitations set by healthcare payers exacerbate the issue, further restricting access to SNS therapies. This financial challenge can impede broader adoption and growth in the market, especially in regions that face healthcare resource limitations or economic constraints.

Market Trends of the Global Sacral Nerve Stimulation (SNS) Market

The Global Sacral Nerve Stimulation (SNS) market is witnessing a significant trend towards the adoption of miniaturization and wireless technology. Manufacturers are increasingly developing compact SNS devices that prioritize patient comfort and convenience, catering to the rising demand for minimally invasive treatments. This focus on smaller devices not only simplifies implantation procedures but also potentially diminishes post-operative complications. Additionally, the incorporation of wireless technology enhances patient monitoring and data collection, enabling remote programming and personalized treatment plans. As a result, this trend promises to reduce patients' reliance on frequent clinic visits, ultimately improving the overall treatment experience and outcomes in SNS therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Sacral Nerve Stimulation (SNS) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Implantable SNS Devices
• External SNS Devices

Global Sacral Nerve Stimulation (SNS) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Urinary and Fecal Incontinence
• Chronic Anal Fissure
• Urge Incontinence
• Others

Global Sacral Nerve Stimulation (SNS) Market Size & CAGR (2025-2032)

• North America (Product, Application)
  • US
  • Canada
• Europe (Product, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedical Life Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kegel8 (Savantini Limited) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EnteroMedics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations